The DOI matches its Crossref record; 232 of the 232 references it cites were found in a registry or an index.
Parenteral anticoagulants in heart disease: Current status and perspectives (Section II): Position Paper of the ESC Working Group on Thrombosis – Task Force on Anticoagulants in Heart Disease
Abstract
Summary: Anticoagulants are a mainstay of cardiovascular therapy, and parenteral anticoagulants have widespread use in cardiology, especially in acute situations. Parenteral anticoagulants include unfractionated heparin, low-molecular-weight heparins, the synthetic pentasaccharides fondaparinux, idraparinux and idrabiotaparinux, and parenteral direct thrombin inhibitors. The several shortcomings of unfractionated heparin and of low-molecular-weight heparins have prompted the development of the other newer agents. Here we review the mechanisms of action, pharmacological properties and side effects of parenteral anticoagulants used in the management of coronary heart disease treated with or without percutaneous coronary interventions, cardioversion for atrial fibrillation, and prosthetic heart valves and valve repair. Using an evidence-based approach, we describe the results of completed clinical trials, highlight ongoing research with currently available agents, and recommend therapeutic options for specific heart diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.176857 · Cited by 8,495
Authors/Task Force Members, Steg, P. G., James, S. K., Atar, D., Badano, L. P., Lundqvist, C. B., Borger, M. A., Di Mario, C., Dickstein, K., Ducrocq, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs215 · Cited by 6,829
Self-citation(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
Developed with the special contribution of the European Heart Rhythm Association (EHRA), Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS), Authors/Task Force Members, Camm, A. J., Kirchhof, P., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Van Gelder, I. C., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,864
Self-citationClinical and Laboratory Standards Institute
(2019) · Springer Reference Medizin · doi:10.1007/978-3-662-48986-4_300416 · Cited by 5,091
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00007 · Cited by 4,793
Pisters, R., Lane, D. A., Nieuwlaat, R., de Vos, C. B., Crijns, H. J. G. M., & Lip, G. Y. H. (2010) · Chest · doi:10.1378/chest.10-0134 · Cited by 4,505
Self-citation2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Lip, G. Y. H., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P., ESC Committee for Practice Guidelines (CPG), et al. (2012) · EP Europace · doi:10.1093/europace/eus305 · Cited by 3,822
Self-citationAuthors/Task Force Members, Vahanian, A., Baumgartner, H., Bax, J., Butchart, E., Dion, R., Filippatos, G., Flachskampf, F., Hall, R., Iung, B., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl428 · Cited by 3,593
Self-citationGuidelines on the management of valvular heart disease (version 2012)
Authors/Task Force Members, Vahanian, A., Alfieri, O., Andreotti, F., Antunes, M. J., Barón-Esquivias, G., Baumgartner, H., Borger, M. A., Carrel, T. P., De Bonis, M., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs109 · Cited by 3,559
Self-citationAuthors/Task Force Members, Hamm, C. W., Bassand, J.-P., Agewall, S., Bax, J., Boersma, E., Bueno, H., Caso, P., Dudek, D., Gielen, S., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr236 · Cited by 3,080
Self-citation2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Lip, G. Y. H., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P., ESC Committee for Practice Guidelines (CPG), et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs253 · Cited by 2,899
Self-citationApixaban in patients with atrial fibrillation
Connolly, S. J., Eikelboom, J., Joyner, C., Diener, H.-C., Hart, R., Golitsyn, S., Flaker, G., Avezum, A., Hohnloser, S. H., Diaz, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007432 · Cited by 2,483
Warkentin, T. E., Levine, M. N., Hirsh, J., Horsewood, P., Roberts, R. S., Gent, M., & Kelton, J. G. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322003 · Cited by 2,328
Authors/Task Force Members, Van de Werf, F., Bax, J., Betriu, A., Blomstrom-Lundqvist, C., Crea, F., Falk, V., Filippatos, G., Fox, K., Huber, K., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn416 · Cited by 2,310
Self-citationBonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O'Gara, P. T., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.007 · Cited by 2,257
Pharmacology and Management of the Vitamin K Antagonists
Ansell, J., Hirsh, J., Hylek, E., Jacobson, A., Crowther, M., & Palareti, G. (2008) · Chest · doi:10.1378/chest.08-0670 · Cited by 2,118
Effect of clopidogrel added to aspirin in patients with atrial fibrillation
The ACTIVE Investigators (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901301 · Cited by 2,102
A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy
Rosendaal, F. R., Cannegieter, S. C., van der Meer, F. J. M., & Briët, E. (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1651587 · Cited by 2,065
Schömig, A., Neumann, F.-J., Kastrati, A., Schühlen, H., Blasini, R., Hadamitzky, M., Walter, H., Zitzmann-Roth, E.-M., Richardt, G., Alt, E., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604253341702 · Cited by 2,028
Guidelines on the management of valvular heart disease (version 2012)
Authors/Task Force Members, Vahanian, A., Alfieri, O., Andreotti, F., Antunes, M. J., Barón-Esquivias, G., Baumgartner, H., Borger, M. A., Carrel, T. P., De Bonis, M., et al. (2012) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezs455 · Cited by 2,009
Self-citationBivalirudin during Primary PCI in Acute Myocardial Infarction
Stone, G. W., Witzenbichler, B., Guagliumi, G., Peruga, J. Z., Brodie, B. R., Dudek, D., Kornowski, R., Hartmann, F., Gersh, B. J., Pocock, S. J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708191 · Cited by 1,867
Petersen, P., Godtfredsen, J., Boysen, G., Andersen, E., & Andersen, B. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91200-2 · Cited by 1,820
A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery Stenting
Leon, M. B., Baim, D. S., Popma, J. J., Gordon, P. C., Cutlip, D. E., Ho, K. K. L., Giambartolomei, A., Diver, D. J., Lasorda, D. M., Williams, D. O., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812033392303 · Cited by 1,815
Stroke Prevention in Atrial Fibrillation Study. Final results.
(1991) · Circulation · doi:10.1161/01.cir.84.2.527 · Cited by 1,696
Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809329 · Cited by 1,577
Mant, J., Hobbs, F. R., Fletcher, K., Roalfe, A., Fitzmaurice, D., Lip, G. Y., & Murray, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61233-1 · Cited by 1,556
Weitz, J. I. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371007 · Cited by 1,533
Self-citation(1990) · New England Journal of Medicine · doi:10.1056/nejm199011293232201 · Cited by 1,530
The Pharmacology and Management of the Vitamin K Antagonists
Ansell, J., Hirsh, J., Poller, L., Bussey, H., Jacobson, A., & Hylek, E. (2004) · Chest · doi:10.1378/chest.126.3_suppl.204s · Cited by 1,528
Dabigatran versus warfarin in patients with mechanical heart valves
Eikelboom, J. W., Connolly, S. J., Brueckmann, M., Granger, C. B., Kappetein, A. P., Mack, M. J., Blatchford, J., Devenny, K., Friedman, J., Guiver, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1300615 · Cited by 1,506
Bivalirudin for Patients with Acute Coronary Syndromes
Stone, G. W., McLaurin, B. T., Cox, D. A., Bertrand, M. E., Lincoff, A. M., Moses, J. W., White, H. D., Pocock, S. J., Ware, J. H., Feit, F., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062437 · Cited by 1,459
Self-citationOlesen, J. B., Lip, G. Y. H., Hansen, M. L., Hansen, P. R., Tolstrup, J. S., Lindhardsen, J., Selmer, C., Ahlehoff, O., Olsen, A.-M. S., Gislason, G. H., et al. (2011) · BMJ · doi:10.1136/bmj.d124 · Cited by 1,428
Self-citationCohen, M., Demers, C., Gurfinkel, E. P., Turpie, A. G. G., Fromell, G. J., Goodman, S., Langer, A., Califf, R. M., Fox, K. A. A., Premmereur, J., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708143370702 · Cited by 1,424
Palareti, G., Leali, N., Coccheri, S., Poggi, M., Manotti, C., D'Angelo, A., Pengo, V., Erba, N., Moia, M., Ciavarella, N., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)01109-9 · Cited by 1,333
Effect of Intensity of Oral Anticoagulation on Stroke Severity and Mortality in Atrial Fibrillation
Hylek, E. M., Go, A. S., Chang, Y., Jensvold, N. G., Henault, L. E., Selby, J. V., & Singer, D. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022913 · Cited by 1,277
Aspirin, Heparin, or Both to Treat Acute Unstable Angina
Théroux, P., Ouimet, H., McCans, J., Latour, J.-G., Joly, P., Lévy, G., Pelletier, E., Juneau, M., Stasiak, J., deGuise, P., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810273191701 · Cited by 1,276
Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa055443 · Cited by 1,228
Hemorrhagic Complications of Anticoagulant Treatment
Levine, M. N., Raskob, G., Landefeld, S., & Kearon, C. (2001) · Chest · doi:10.1378/chest.119.1_suppl.108s · Cited by 1,134
2006 WRITING COMMITTEE MEMBERS, Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.190748 · Cited by 1,114
Canadian atrial fibrillation anticoaguiation (CAFA) study
Connolly, S. J., Laupacis, A., Gent, M., Roberts, R. S., Cairns, J. A., & Joyner, C. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90585-w · Cited by 1,111
Garcia, D. A., Baglin, T. P., Weitz, J. I., & Samama, M. M. (2012) · Chest · doi:10.1378/chest.11-2291 · Cited by 1,091
Self-citationLip, G. Y. H., Frison, L., Halperin, J. L., & Lane, D. A. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.024 · Cited by 1,080
Self-citationWarfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation
(1993) · New England Journal of Medicine · doi:10.1056/nejm199301143280227 · Cited by 1,067
Antman, E. M., McCabe, C. H., Gurfinkel, E. P., Turpie, A. G. G., Bernink, P. J. L. M., Salein, D., Bayes de Luna, A., Fox, K., Lablanche, J.-M., Radley, D., et al. (1999) · Circulation · doi:10.1161/01.cir.100.15.1593 · Cited by 1,052
Higashi, M. K. (2002) · JAMA · doi:10.1001/jama.287.13.1690 · Cited by 1,048
Treatment and Prevention of Heparin-Induced Thrombocytopenia
Linkins, L.-A., Dans, A. L., Moores, L. K., Bona, R., Davidson, B. L., Schulman, S., & Crowther, M. (2012) · Chest · doi:10.1378/chest.11-2303 · Cited by 1,018
Guidelines on myocardial revascularization
The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) (2010) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2010.08.019 · Cited by 1,004
Heparin and Low-Molecular-Weight Heparin
Hirsh, J., & Raschke, R. (2004) · Chest · doi:10.1378/chest.126.3_suppl.188s · Cited by 971
The OASIS-6 Trial Group* (2006) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.295.13.joc60038 · Cited by 906
Warfarin, Aspirin, or Both after Myocardial Infarction
Hurlen, M., Abdelnoor, M., Smith, P., Erikssen, J., & Arnesen, H. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020496 · Cited by 846
Self-citationHylek, E. M., Skates, S. J., Sheehan, M. A., & Singer, D. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608223350802 · Cited by 789
The RISC Group (1990) · The Lancet · doi:10.1016/0140-6736(90)92336-g · Cited by 781
Raschke, R. A., Reilly, B. M., Guidry, J. R., Fontana, J. R., & Srinivas, S. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-9-199311010-00002 · Cited by 743
Heparin-Induced Thrombocytopenia
Arepally, G. M., & Ortel, T. L. (2006) · New England Journal of Medicine · doi:10.1056/nejmcp052967 · Cited by 723
Hull, R. D., Raskob, G. E., Hirsh, J., Jay, R. M., Leclerc, J. R., Geerts, W. H., Rosenbloom, D., Sackett, D. L., Anderson, C., Harrison, L., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610303151801 · Cited by 722
Madden, C. (1991) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(05)81237-5 · Cited by 691
2012 Focused Update of the ESC Guidelines for the Management of Atrial Fibrillation
Camm, A. J., Lip, G. Y. H., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., & Kirchhof, P. (2013) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2012.11.003 · Cited by 687
Self-citationLow-molecular-weight heparin during instability in coronary artery disease
Fragmin during Instability in Coronary Artery Disease (FRISC) study group (1996) · The Lancet · doi:10.1016/s0140-6736(96)91270-2 · Cited by 685
Basu, D., Gallus, A., Hirsh, J., & Cade, J. (1972) · New England Journal of Medicine · doi:10.1056/nejm197208172870703 · Cited by 661
The Effect of Warfarin on Mortality and Reinfarction after Myocardial Infarction
Smith, P., Arnesen, H., & Holme, I. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007193230302 · Cited by 638
Self-citationAntithrombotic and Thrombolytic Therapy for Valvular Disease
Whitlock, R. P., Sun, J. C., Fremes, S. E., Rubens, F. D., & Teoh, K. H. (2012) · Chest · doi:10.1378/chest.11-2305 · Cited by 625
Enoxaparin versus Unfractionated Heparin with Fibrinolysis for ST-Elevation Myocardial Infarction
Antman, E. M., Morrow, D. A., McCabe, C. H., Murphy, S. A., Ruda, M., Sadowski, Z., Budaj, A., López-Sendón, J. L., Guneri, S., Jiang, F., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060898 · Cited by 609
Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm
Homma, S., Thompson, J. L. P., Pullicino, P. M., Levin, B., Freudenberger, R. S., Teerlink, J. R., Ammon, S. E., Graham, S., Sacco, R. L., Mann, D. L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202299 · Cited by 584
Self-citationBertrand, M. E., Legrand, V., Boland, J., Fleck, E., Bonnier, J., Emmanuelson, H., Vrolix, M., Missault, L., Chierchia, S., Casaccia, M., et al. (1998) · Circulation · doi:10.1161/01.cir.98.16.1597 · Cited by 583
(1997) · ACC Current Journal Review · doi:10.1016/s1062-1458(97)83303-x · Cited by 539
Hart, R. G., Pearce, L. A., McBride, R., Rothbart, R. M., & Asinger, R. W. (1999) · Stroke · doi:10.1161/01.str.30.6.1223 · Cited by 533
Klein, W., Buchwald, A., Hillis, S. E., Monrad, S., Sanz, G., Turpie, A. G. G., van der Meer, J., Olaisson, E., Undeland, S., & Ludwig, K. (1997) · Circulation · doi:10.1161/01.cir.96.1.61 · Cited by 526
Olesen, J., Torp-Pedersen, C., Hansen, M., & Lip, G. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-03-0175 · Cited by 485
Self-citationOler, A. (1996) · JAMA · doi:10.1001/jama.276.10.811 · Cited by 483
Apostolakis, S., Sullivan, R. M., Olshansky, B., & Lip, G. Y. H. (2013) · Chest · doi:10.1378/chest.13-0054 · Cited by 482
Self-citationAntman, E. M., Cohen, M., Radley, D., McCabe, C., Rush, J., Premmereur, J., & Braunwald, E. (1999) · Circulation · doi:10.1161/01.cir.100.15.1602 · Cited by 476
Friberg, L., Rosenqvist, M., & Lip, G. Y. H. (2012) · Circulation · doi:10.1161/circulationaha.111.055079 · Cited by 454
Self-citationStone, G. W., Witzenbichler, B., Guagliumi, G., Peruga, J. Z., Brodie, B. R., Dudek, D., Kornowski, R., Hartmann, F., Gersh, B. J., Pocock, S. J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60764-2 · Cited by 452
Eikelboom, J. W., Anand, S. S., Malmberg, K., Weitz, J. I., Ginsberg, J. S., & Yusuf, S. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02324-2 · Cited by 447
Self-citationUrban, P., Macaya, C., Rupprecht, H.-J., Kiemeneij, F., Emanuelsson, H., Fontanelli, A., Pieper, M., Wesseling, T., & Sagnard, L. (1998) · Circulation · doi:10.1161/01.cir.98.20.2126 · Cited by 445
Self-monitoring of oral anticoagulation: a systematic review and meta-analysis
Heneghan, C., Alonso-Coello, P., Garcia-Alamino, J., Perera, R., Meats, E., & Glasziou, P. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68139-7 · Cited by 438
Lip, G., Lindhardsen, J., Lane, D., Ahlehoff, O., Hansen, M., Raunsø, J., Tolstrup, J., Hansen, P., Gislason, G., Torp-Pedersen, C., et al. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-05-0364 · Cited by 428
Self-citationvan Es, R. F., Jonker, J. J., Verheugt, F. W., Deckers, J. W., & Grobbee, D. E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09409-6 · Cited by 423
Self-citationLamberts, M., Olesen, J. B., Ruwald, M. H., Hansen, C. M., Karasoy, D., Kristensen, S. L., Køber, L., Torp-Pedersen, C., Gislason, G. H., & Hansen, M. L. (2012) · Circulation · doi:10.1161/circulationaha.112.114967 · Cited by 413
Self-citationMassie, B. M., Collins, J. F., Ammon, S. E., Armstrong, P. W., Cleland, J. G. F., Ezekowitz, M., Jafri, S. M., Krol, W. F., O'Connor, C. M., Schulman, K. A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.801753 · Cited by 408
Cleland, J. G. F., Findlay, I., Jafri, S., Sutton, G., Falk, R., Bulpitt, C., Prentice, C., Ford, I., Trainer, A., & Poole-Wilson, P. A. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.03.010 · Cited by 407
Kirchhof, P., Ammentorp, B., Darius, H., De Caterina, R., Le Heuzey, J.-Y., Schilling, R. J., Schmitt, J., & Zamorano, J. L. (2014) · EP Europace · doi:10.1093/europace/eut263 · Cited by 404
Wallentin, L., Goldstein, P., Armstrong, P. W., Granger, C. B., Adgey, A. A. J., Arntz, H. R., Bogaerts, K., Danays, T., Lindahl, B., Mäkijärvi, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000081659.72985.a8 · Cited by 384
Self-citationCohen, M., Adams, P. C., Parry, G., Xiong, J., Chamberlain, D., Wieczorek, I., Fox, K. A., Chesebro, J. H., Strain, J., & Keller, C. (1994) · Circulation · doi:10.1161/01.cir.89.1.81 · Cited by 378
Heneghan, C., Ward, A., Perera, R., Bankhead, C., Fuller, A., Stevens, R., Bradford, K., Tyndel, S., Alonso-Coello, P., Ansell, J., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61294-4 · Cited by 372
Hughes, M., Lip, G. Y. H., & on behalf of the Guideline Development Group for the NICE national clinical guideline for management of atrial fibrillation in primary and secondary care (2008) · Thrombosis and Haemostasis · doi:10.1160/th07-08-0508 · Cited by 371
Self-citationWarfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups
Limdi, N. A., Wadelius, M., Cavallari, L., Eriksson, N., Crawford, D. C., Lee, M.-T. M., Chen, C.-H., Motsinger-Reif, A., Sagreiya, H., Liu, N., et al. (2010) · Blood · doi:10.1182/blood-2009-12-255992 · Cited by 370
Enoxaparin versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention
Montalescot, G., White, H. D., Gallo, R., Cohen, M., Steg, P. G., Aylward, P. E. G., Bode, C., Chiariello, M., King, S. B., Harrington, R. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052711 · Cited by 359
Apostolakis, S., Lane, D. A., Guo, Y., Buller, H., & Lip, G. Y. H. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.06.019 · Cited by 358
Self-citationRecommendations for the management of patients after heart valve surgery
Butchart, E. G., Gohlke-Bärwolf, C., Antunes, M. J., Tornos, P., De Caterina, R., Cormier, B., Prendergast, B., Iung, B., Bjornstad, H., Leport, C., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi426 · Cited by 358
Self-citationLow-Molecular-Weight Heparin (Fragmin) During Instability in Coronary Artery Disease (FRISC)
Swahn, E., & Wallentin, L. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00486-4 · Cited by 354
Self-citationPetersen, J. L., Mahaffey, K. W., Hasselblad, V., Antman, E. M., Cohen, M., Goodman, S. G., Langer, A., Blazing, M. A., Le-Moigne-Amrani, A., de Lemos, J. A., et al. (2004) · JAMA · doi:10.1001/jama.292.1.89 · Cited by 333
Gurfinkel, E. P., Manos, E. J., Mejaíl, R. I., Cerdá, M. A., Duronto, E. A., García, C. N., Daroca, A. M., & Mautner, B. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)80001-w · Cited by 326
Systemic Embolism and Anticoagulant Prophylaxis in Rheumatic Heart Disease
Szekely, P. (1964) · BMJ · doi:10.1136/bmj.1.5392.1209 · Cited by 325
Montalescot, G., Zeymer, U., Silvain, J., Boulanger, B., Cohen, M., Goldstein, P., Ecollan, P., Combes, X., Huber, K., Pollack, C., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60876-3 · Cited by 325
Self-citationTurpie, A. G. G., Robinson, J. G., Doyle, D. J., Mulji, A. S., Mishkel, G. J., Sealey, B. J., Cairns, J. A., Skingley, L., Hirsh, J., & Gent, M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902093200604 · Cited by 323
Abciximab and Heparin versus Bivalirudin for Non–ST-Elevation Myocardial Infarction
Kastrati, A., Neumann, F.-J., Schulz, S., Massberg, S., Byrne, R. A., Ferenc, M., Laugwitz, K.-L., Pache, J., Ott, I., Hausleiter, J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1109596 · Cited by 314
Huber, K., Andreotti, F., Arnesen, H., Airaksinen, K. J., Cuisset, T., Kirchhof, P., Marín, F., & Lip, G. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-08-0580 · Cited by 303
Self-citationComparative Pharmacokinetics of Vitamin K Antagonists
Ufer, M. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544120-00003 · Cited by 303
Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction
(1997) · The Lancet · doi:10.1016/s0140-6736(97)01180-x · Cited by 301
Banerjee, A., Lane, D. A., Torp-Pedersen, C., & Lip, G. Y. H. (2012) · Thrombosis and Haemostasis · doi:10.1160/th11-11-0784 · Cited by 301
Self-citationCalibration of Reference Thromboplastins and Standardisation of the Prothrombin Time Ratio
Kirkwood, T. B. L. (1983) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657371 · Cited by 300
Cairns, J. A., Connolly, S., McMurtry, S., Stephenson, M., & Talajic, M. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2010.11.007 · Cited by 292
Andreotti, F., Testa, L., Biondi-Zoccai, G. G. L., & Crea, F. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi485 · Cited by 289
Self-citationBleeding During Antithrombotic Therapy in Patients With Atrial Fibrillation
(1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440040081009 · Cited by 283
Sato, H., Ishikawa, K., Kitabatake, A., Ogawa, S., Maruyama, Y., Yokota, Y., Fukuyama, T., Doi, Y., Mochizuki, S., Izumi, T., et al. (2006) · Stroke · doi:10.1161/01.str.0000198839.61112.ee · Cited by 282
Hall, P., Nakamura, S., Maiello, L., Itoh, A., Blengino, S., Martini, G., Ferraro, M., & Colombo, A. (1996) · Circulation · doi:10.1161/01.cir.93.2.215 · Cited by 281
Fauchier, L., Hylek, E., Knight, E., Lane, D., Levi, M., Marin, F., Palareti, G., Collet, J.-P., Rubboli, A., Poli, D., et al. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-10-0690 · Cited by 280
Self-citationIncreased embolic risk in patients with left ventricular thrombi.
Stratton, J. R., & Resnick, A. D. (1987) · Circulation · doi:10.1161/01.cir.75.5.1004 · Cited by 276
Pettilä, V., Leinonen, P., Markkola, A., Hiilesmaa, V., & Kaaja, R. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1612970 · Cited by 275
Knatterud, G. L., Rosenberg, Y., Campeau, L., Geller, N. L., Hunninghake, D. B., Forman, S. A., Forrester, J. S., Gobel, F. L., Herd, J. A., Hickey, A., et al. (2000) · Circulation · doi:10.1161/01.cir.102.2.157 · Cited by 274
VAN STAA, T. P., SETAKIS, E., DI TANNA, G. L., LANE, D. A., & LIP, G. Y. H. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04085.x · Cited by 272
Self-citationEffect of home testing of international normalized ratio on clinical events
Matchar, D. B., Jacobson, A., Dolor, R., Edson, R., Uyeda, L., Phibbs, C. S., Vertrees, J. E., Shih, M.-C., Holodniy, M., & Lavori, P. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002617 · Cited by 266
Ezekowitz (1992) · New England Journal of Medicine · Cited by 266
New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes
De Caterina, R., Husted, S., Wallentin, L., De Caterina, R., Husted, S., Wallentin, L., Andreotti, F., Arnesen, H., Bachmann, F., Baigent, C., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.02.008 · Cited by 265
Self-citationSelf-monitoring and self-management of oral anticoagulation
Heneghan, C. J., Garcia-Alamino, J. M., Spencer, E. A., Ward, A. M., Perera, R., Bankhead, C., Alonso Coello, P., Fitzmaurice, D., Mahtani, K. R., & Onakpoya, I. J. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003839.pub3 · Cited by 256
Silent Cerebral Infarction in Patients With Nonrheumatic Atrial Fibrillation
Ezekowitz, M. D., James, K. E., Nazarian, S. M., Davenport, J., Broderick, J. P., Gupta, S. R., Thadani, V., Meyer, M. L., & Bridgers, S. L. (1995) · Circulation · doi:10.1161/01.cir.92.8.2178 · Cited by 250
Montalescot, G., Philippe, F., Ankri, A., Vicaut, E., Bearez, E., Poulard, J. E., Carrie, D., Flammang, D., Dutoit, A., Carayon, A., et al. (1998) · Circulation · doi:10.1161/01.cir.98.4.294 · Cited by 250
Antiplatelet agents for the treatment and prevention of atherothrombosis
Patrono, C., Andreotti, F., Arnesen, H., Badimon, L., Baigent, C., Collet, J.-P., De Caterina, R., Gulba, D., Huber, K., Husted, S., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr373 · Cited by 243
Self-citationAnderson, J. L., Horne, B. D., Stevens, S. M., Woller, S. C., Samuelson, K. M., Mansfield, J. W., Robinson, M., Barton, S., Brunisholz, K., Mower, C. P., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.070920 · Cited by 229
Lip, G. Y. H., Huber, K., Andreotti, F., Arnesen, H., Airaksinen, J. K., Cuisset, T., Kirchhof, P., & Marin, F. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq117 · Cited by 229
Self-citationFiore, L. D., Ezekowitz, M. D., Brophy, M. T., Lu, D., Sacco, J., & Peduzzi, P. (2002) · Circulation · doi:10.1161/hc0502.103329 · Cited by 224
Multicentre randomised study of computerised anticoagulant dosage
Poller, L., Shiach, C., MacCallum, P., Johansen, A., Münster, A., Magalhäes, A., & Jespersen, J. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04147-6 · Cited by 222
Self-citationEfficacy of Antithrombotic Therapy in Chronic Heart Failure: The HELAS Study
Cokkinos, D. V., Haralabopoulos, G. C., Kostis, J. B., Toutouzas, P. K., & for the HELAS investigators (2006) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2006.02.012 · Cited by 217
Collet, J. P., Montalescot, G., Lison, L., Choussat, R., Ankri, A., Drobinski, G., Sotirov, I., & Thomas, D. (2001) · Circulation · doi:10.1161/01.cir.103.5.658 · Cited by 216
OLESEN, J. B., LIP, G. Y. H., HANSEN, P. R., LINDHARDSEN, J., AHLEHOFF, O., ANDERSSON, C., WEEKE, P., HANSEN, M. L., GISLASON, G. H., & TORP‐PEDERSEN, C. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04378.x · Cited by 201
Self-citationGoodman, S. G., Fitchett, D., Armstrong, P. W., Tan, M., & Langer, A. (2003) · Circulation · doi:10.1161/01.cir.0000050144.67910.13 · Cited by 199
Roldán, V., Marín, F., Fernández, H., Manzano-Fernandez, S., Gallego, P., Valdés, M., Vicente, V., & Lip, G. Y. H. (2013) · Chest · doi:10.1378/chest.12-0608 · Cited by 193
Self-citationThe FUTURA/OASIS-8 Trial Group, Steg, P. G., Jolly, S. S., Mehta, S. R., Afzal, R., Xavier, D., Rupprecht, H.-J., Lopez-Sendon, J. L., Budaj, A., Diaz, R., et al. (2010) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.2010.1320 · Cited by 191
Van de Werf, F., Brueckmann, M., Connolly, S. J., Friedman, J., Granger, C. B., Härtter, S., Harper, R., Kappetein, A. P., Lehr, T., Mack, M. J., et al. (2012) · American Heart Journal · doi:10.1016/j.ahj.2012.03.011 · Cited by 185
Husted, S., Wallentin, L., Andreotti, F., Arnesen, H., Bachmann, F., Baigent, C., Huber, K., Jespersen, J., Kristensen, S., Lip, G. Y. H., et al. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-10-0772 · Cited by 182
Self-citationStellbrink, C., Nixdorff, U., Hofmann, T., Lehmacher, W., Daniel, W. G., Hanrath, P., Geller, C., Mügge, A., Sehnert, W., Schmidt-Lucke, C., et al. (2004) · Circulation · doi:10.1161/01.cir.0000120509.64740.dc · Cited by 181
A coding VKORC1 Asp36Tyr polymorphism predisposes to warfarin resistance
Loebstein, R., Dvoskin, I., Halkin, H., Vecsler, M., Lubetsky, A., Rechavi, G., Amariglio, N., Cohen, Y., Ken-Dror, G., Almog, S., et al. (2007) · Blood · doi:10.1182/blood-2006-08-038984 · Cited by 171
Coussement, P. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2777 · Cited by 169
Becker, R. C., Spencer, F. A., Gibson, M., Rush, J. E., Sanderink, G., Murphy, S. A., Ball, S. P., & Antman, E. M. (2002) · American Heart Journal · doi:10.1067/mhj.2002.120774 · Cited by 166
Predictors of Systemic Embolism in Patients with Mitral Stenosis: A Prospective Study
Chiang, C.-W., Lo, S.-K., Ko, Y.-S., Cheng, N.-J., Lin, P. J., & Chang, C.-H. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-11-199806010-00001 · Cited by 165
Omran, H., Bauersachs, R., Rübenacker, S., Goss, F., & Hammerstingl, C. (2012) · Thrombosis and Haemostasis · doi:10.1160/th11-12-0827 · Cited by 164
Cohen, M., Théroux, P., Borzak, S., Frey, M. J., White, H. D., Van Mieghem, W., Senatore, F., Lis, J., Mukherjee, R., Harris, K., et al. (2002) · American Heart Journal · doi:10.1067/mhj.2002.126115 · Cited by 160
Camm, A. J., Toft, E., Torp-Pedersen, C., Vijayaraman, P., Juul-Moller, S., Ip, J., Beatch, G. N., Dickinson, G., Wyse, D. G., & for the Scene 2 Investigators (2012) · Europace · doi:10.1093/europace/eur416 · Cited by 159
International Normalized Ratios (INR): the first 20 years
Poller, L. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00775.x · Cited by 157
Anticoagulants in heart disease: current status and perspectives
Caterina, R. D., Husted, S., Wallentin, L. C., Agnelli, G., Bachmann, F., Baigent, C., Jespersen, J., Kristensen, S., Montalescot, G., Siegbahn, A. G., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl492 · Cited by 147
Self-citationThe CHADS2 score for stroke risk stratification in atrial fibrillation – friend or foe?
Eikelboom, J. W., & Karthikeyan, G. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-11-0757 · Cited by 146
Brouwer, M. A., van den Bergh, P. J. P. C., Aengevaeren, W. R. M., Veen, G., Luijten, H. E., Hertzberger, D. P., Boven, A. J. V., Vromans, R. P. J. W., Uijen, G. J. H., & Verheugt, F. W. A. (2002) · Circulation · doi:10.1161/01.cir.0000024408.81821.32 · Cited by 146
Self-citationEikelboom, J. W., Quinlan, D. J., Mehta, S. R., Turpie, A. G. G., Menown, I. B. A., & Yusuf, S. (2005) · Circulation · doi:10.1161/circulationaha.105.573550 · Cited by 143
Simoons, M. L., Bobbink, I. W. G., Boland, J., Gardien, M., Klootwijk, P., Lensing, A. W. A., Rużyłło, W., Umans, V. A. W. M., Vahanian, A. S., de Werf, F. V., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.051 · Cited by 141
Fondaparinux for the treatment of patients with acute heparininduced thrombocytopenia
Finch, C. K., Howard, A. H., Minhas, S., & Lobo, B. (2007) · Thrombosis and Haemostasis · doi:10.1160/th07-04-0252 · Cited by 139
Lópes, R. D., Hylek, E. M., & Garcia, D. A. (2010) · Thrombosis and Haemostasis · doi:10.1160/th10-07-0491 · Cited by 134
Holdright, D. R., Patel, D. J., Cunningham, A. D., Thomas, R. D., Hubbard, W. N., Hendry, G., Sutton, G. C., & Fox, K. M. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90539-8 · Cited by 133
Risk Factors for Thromboembolic Complications in Chronic Atrial Fibrillation
Petersen, P. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.4.819 · Cited by 130
Ventricular thrombi and thromboembolism in dilated cardiomyopathy: A prospective follow-up study
Falk, R. H., Foster, E., & Coats, M. H. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)90757-m · Cited by 126
Lin, L., Lee, C., Yu, C., Tsai, C., Lai, L.-P., Hwang, J., Chen, P., & Lin, J.-L. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.03.033 · Cited by 124
Eumann, N., Astrati, A. D. K., Chühlen, H. E. S., Lasini, R. U. B., Adamitzky, M. A. H., Alter, H. A. W., Va, E., Ichardt, G. E. R., Chmitt, C. L. S., & U, K. U. (1996) · Cited by 124
Recognition, treatment, and prevention of heparin-induced thrombocytopenia: Review and update
Greinacher, A., & Warkentin, T. E. (2005) · Thrombosis Research · doi:10.1016/j.thromres.2005.07.012 · Cited by 123
Poller, L., Keown, M., Ibrahim, S. A., Lowe, G. D. O., Moia, M., Turpie, A. G. G., Roberts, C., van den Besselaar, A. M. H. P., van der Meer, F. J. M., Tripodi, A., et al. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.02959.x · Cited by 120
Self-citationMehta, S. R., Steg, P. G., Granger, C. B., Bassand, J., Faxon, D. P., Weitz, J. I., Afzal, R., Rush, B., Peters, R. J. G., Natarajan, M. K., et al. (2005) · Circulation · doi:10.1161/01.cir.0000158485.70761.67 · Cited by 119
Self-citationGadisseur, A., Breukink-Engbers, W. G. M., van der Meer, F. J. M., van den Besselaar, A. M. H. P., Sturk, A., & Rosendaal, F. R. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.21.2639 · Cited by 118
Drug interactions with warfarin: what clinicians need to know
Juurlink, D. N. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.070946 · Cited by 113
Gadisseur, A., Kaptein, A. A., Breukink-Engbers, W. G. M., et al. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00659.x · Cited by 111
Faxon, D. P., Eikelboom, J. W., Berger, P. B., Holmes, D. R., Bhatt, D. L., Moliterno, D. J., Becker, R. C., & Angiolillo, D. J. (2011) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.111.965186 · Cited by 108
Incident stroke after discharge from the hospital with a diagnosis of atrial fibrillation
Frost, L., Engholm, G., Johnsen, S. P., Møller, H., & Husted, S. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00415-5 · Cited by 103
Self-citationMassie, B. M., Krol, W. F., Ammon, S. E., Armstrong, P. W., Cleland, J. G. F., Collins, J. F., Ezekowitz, M. D., Jafri, S. M., O’Connor, C. M., Packer, M., et al. (2004) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2004.02.006 · Cited by 101
Christensen, T. D., & Larsen, T. B. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04568.x · Cited by 99
van Schie, R. M., Wessels, J. A. M., le Cessie, S., de Boer, A., Schalekamp, T., van der Meer, F. J. M., Verhoef, T. I., van Meegen, E., Rosendaal, F. R., der Zee, A. H. M., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr116 · Cited by 99
Wawrzyńska, L., Tomkowski, W. Z., Przedlacki, J., Hajduk, B., & Torbicki, A. (2003) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000073848 · Cited by 96
Rao, L., Rapaport, S., & Hoang, A. (1993) · Blood · doi:10.1182/blood.v81.10.2600.2600 · Cited by 96
Cohen, M. C., Adams, P. C., Hawkins, L. A., Bach, M., & Fuster, V. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)91155-y · Cited by 95
Prediction of Warfarin Dose: Why, When and How?
Eriksson, N., & Wadelius, M. (2012) · Pharmacogenomics · doi:10.2217/pgs.11.184 · Cited by 93
Frykman, V. (2001) · European Heart Journal · doi:10.1053/euhj.2000.2300 · Cited by 93
Assessing the Risk of Bleeding in Patients With Atrial Fibrillation
Lip, G. Y. H., Banerjee, A., Lagrenade, I., Lane, D. A., Taillandier, S., & Fauchier, L. (2012) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.112.972869 · Cited by 90
Self-citationSchulz, S., Mehilli, J., Neumann, F.-J., Schuster, T., Maßberg, S., Valina, C. M., Seyfarth, M., Pache, J., Laugwitz, K. L., Büttner, H. J., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq330 · Cited by 87
Schulman, S., Parpia, S., Stewart, C., Rudd-Scott, L., Julian, J. A., & Levine, M. N. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-10-201111150-00003 · Cited by 86
Smith, J. G., Wieloch, M., Koul, S. M., Braun, O. Ö., Lumsden, J., Rydell, E., Öhman, J. N., Scherstén, F., Svensson, P. J., & van der Pals, J. (2012) · EuroIntervention · doi:10.4244/eijv8i6a105 · Cited by 85
Ellis, D., Usman, M. H., Milner, P. G., Canafax, D. M., & Ezekowitz, M. D. (2009) · Circulation · doi:10.1161/circulationaha.109.856120 · Cited by 85
Anticoagulant Therapy for Percutaneous Coronary Intervention
Rao, S. V., & Ohman, E. M. (2010) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.109.884478 · Cited by 85
Bates, S. M., Weitz, J. I., Johnston, M., Hirsh, J., & Ginsberg, J. S. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.3.385 · Cited by 84
Self-citationThe Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01118-9 · Cited by 83
Warfarin and vitamin K intake in the era of pharmacogenetics
Lurie, Y., Loebstein, R., Kurnik, D., Almog, S., & Halkin, H. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03672.x · Cited by 82
Apostolakis, S. Z., Lane, D. A., Guo, Y., Buller, H. R., & Lip, G. Y. H. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.10.010 · Cited by 81
Self-citationGuo, Y., Apostolakis, S. Z., Blann, A. D., Wang, H., Zhao, X., Zhang, Y., Zhang, D., Ma, J., Wang, Y., & Lip, G. Y. H. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.10.052 · Cited by 80
Self-citationNavarese, E. P., Luca, G. D., Castriota, F., Koziński, M., GURBEL, P. A., Gibson, C. M., Andreotti, F., Buffon, A., Siller-Matula, J. M., Sukiennik, A., et al. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04445.x · Cited by 80
Self-citationFactor Xa and thrombin as targets for new oral anticoagulants
Weitz, J. I. (2010) · Thrombosis Research · doi:10.1016/s0049-3848(10)70147-x · Cited by 80
Self-citationLisman, T., Bijsterveld, N. R., Adelmeijer, J., Meijers, J. C. M., Levi, M. M., Nieuwenhuis, H. K., & de Groot, P. G. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00536.x · Cited by 75
Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm
Ponikowski, P. P., Andreotti, F., Anker, S. D., Filippatos, G., Homma, S., Morais, J., Pullicino, P. M., Rasmussen, L., Marín, F. R., Lane, D. A., et al. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-08-0578 · Cited by 73
Self-citationAiraksinen, J. K. E., Cuisset, T., Marín, F. R., Rubboli, A., Rubboli, A., Lip, G. Y. H., & Huber, K. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-08-0602 · Cited by 72
Self-citationFERDER, N. S., EBY, C. S., Birman-Deych, E., Harris, J. K., Ridker, P. M., Milligan, P. E., Goldhaber, S. Z., KING, C. R., Giri, T. K., McLeod, H. L., et al. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03677.x · Cited by 72
In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulation
Linkins, L., Julian, J. A., Rischke, J. A., Hirsh, J., & Weitz, J. I. (2002) · Thrombosis Research · doi:10.1016/s0049-3848(02)00340-7 · Cited by 72
Self-citation
Cited by
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P. E., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 9,971
Self-citation2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · Europace · doi:10.1093/europace/euw295 · Cited by 6,439
Self-citation2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
Self-citation2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
Authors/Task Force Members, Konstantinides, S. V., Torbicki, A., Agnelli, G., Danchin, N., Fitzmaurice, D., Galiè, N., Gibbs, J. S. R., Huisman, M. V., Humbert, M., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu283 · Cited by 3,128
Self-citation2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403
Self-citation
Metadata
- Authors
- Husted, S., Wallentin, L., Andreotti, F., Arnesen, H., Bachmann, F., Baigent, C., Huber, K., Jespersen, J., Kristensen, S., Lip, G. Y. H., Morais, J., Rasmussen, L., Siegbahn, A., Verheugt, F. W. A., Weitz, J. I., & De Caterina, R.
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 2013
- Volume
- 109
- Issue
- 05
- Pages
- 769-786
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W1970914415
- Cited by
- 364
- References
- 232
- FWCI
- 46.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.